Hospital
Missouri Baptist Medical Center
Missouri Baptist Medical Center was paid $1.30M by Medicaid between Jan 2018 and Nov 2024, across 61 billing codes. Its largest line is X4011, State-specific procedure code — 15% of everything it billed.
33Billing provider infoMISSOURI BAPTIST MEDICAL CENTER
SAINT LOUIS, MO 63131
SAINT LOUIS, MO 63131
33aNPI1487663506assigned 08/07/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.30M
24GClaims22,447
24DCodes billed61
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Missouri
Rank by total paid#47 of 74
Median peer was paid$4.44M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,180 | $148K | |
| 2019 | 2,057 | $331K | |
| 2020 | 966 | $99K | |
| 2021 | 1,926 | $78K | |
| 2022 | 5,011 | $249K | |
| 2023 | 7,733 | $303K | |
| 2024incomplete | 3,574 | $89K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| X4011 | State-specific procedure code | 15% | 525 | 479 | $198K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 999 | 916 | $172K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 690 | 642 | $160K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 982 | 954 | $151K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10.0% | 4,921 | 4,615 | $129K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.8% | 705 | 657 | $62K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3.9% | 522 | 519 | $50K |
| 80053 | Comprehensive metabolic panel | 3.8% | 3,750 | 3,578 | $49K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2.3% | 428 | 218 | $29K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.1% | 901 | 843 | $27K |
| X4006 | 1.6% | 36 | 30 | $21K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1.5% | 521 | 518 | $19K |
49 more codes
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 280 | $17K |
| Y7506 | 1.2% | 157 | $16K | |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 601 | $14K |
| 81001 | 1.1% | 416 | $14K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1.1% | 38 | $14K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.0% | 356 | $13K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 338 | $13K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 92 | $13K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 57 | $12K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 76 | $8K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 546 | $7K |
| 80061 | Lipid panel | <1% | 651 | $7K |
| 87660 | <1% | 192 | $7K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 332 | $7K |
| 87480 | <1% | 160 | $6K | |
| 84484 | <1% | 432 | $6K | |
| 87510 | <1% | 75 | $5K | |
| 87081 | <1% | 583 | $5K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 87 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 156 | $4K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 18 | $4K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 103 | $4K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 57 | $4K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 64 | $3K |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 105 | $3K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 16 | $2K |
| 80081 | <1% | 13 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 94 | $2K |
| 81025 | <1% | 186 | $2K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 112 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 145 | $2K |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | <1% | 46 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 65 | $700.00 |
| 86850 | <1% | 13 | $500.02 | |
| 84439 | <1% | 67 | $487.85 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 28 | $427.09 |
| 86696 | <1% | 28 | $378.74 | |
| 83690 | <1% | 109 | $365.30 | |
| 86592 | <1% | 129 | $338.78 | |
| 86695 | <1% | 28 | $258.03 | |
| 87340 | <1% | 29 | $207.71 | |
| 86140 | <1% | 49 | $180.77 | |
| 81003 | <1% | 86 | $99.64 | |
| 85652 | <1% | 49 | $94.20 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 35 | $47.81 |
| 85027 | <1% | 13 | $47.74 | |
| 84550 | <1% | 16 | $35.64 | |
| J3490 | Unclassified drugs | 0% | 124 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialABAD, ANN (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Missouri Baptist Physician Services LLC | Saint Louis, MO | $150K |
| Missouri Baptist Medical Center | Saint Louis, MO | $103K |
| Missouri Baptist Medical Center | Saint Louis, MO | $90K |
| MB Professional Billing Services, LLC | Saint Louis, MO | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.